Knight Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Knight Capital Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$5.8M	Buy	+129,833	New	+$5.64M	0.11%	122

Other funds holding BMY

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Knight Capital Group's BMY Position: Q2 2013 in Review

Knight Capital Group opened a new position in Bristol-Myers Squibb (BMY) in Q2 2013: 129,833 shares worth $5.8M. The stake represents 0.11% of the portfolio and ranks #122 among its holdings.

1,178 funds tracked by Wall St. Rank hold BMY as of Q2 2013.

Knight Capital Group held 129,833 shares of Bristol-Myers Squibb worth $5.8M as of Q2 2013.
Bristol-Myers Squibb was a new Knight Capital Group position in Q2 2013.
Bristol-Myers Squibb made up 0.11% of Knight Capital Group's portfolio in Q2 2013, its #122 holding.
1,178 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.